Press Releases
Trophos completes pivotal phase II/III study of olesoxime in Spinal Muscular Atrophy (SMA)
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology,...
News
Breakthrough by researchers could lead to new treatment for heart attack
The stop and start of blood flow to the heart during and after a heart attack causes severe damage to heart cells, reducing their...
News
Stem cell breakthrough could set up future transplant therapies
A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient...
Press Releases
AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused on ...
Press Releases
3rd Biotechnology World Congress an event by Eureka Science Ltd announced the list of Advisory Board Members
3rd Biotechnology World Congress hosted by Eureka Science Ltd. is a highly reputed event withing the industry. In the year 2014 is is getting...
Press Releases
6th International Conference on Drug Discovery and Therapy announced the list of Advisory Board Members
6th International Conference on Drug Discovery and Therapy, a highly reputed event withing the sector which is hosted by Eureka Science Ltd. is getting...
Press Releases
Advanced research instrumentation pioneer Oxford Optronix to exhibit at Neuroscience 2013
Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries will demonstrate its latest innovative products for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read